🦊/Companies

Scentian Bio

Founded 2021 · 18 employees on LinkedIn · 12 known investors

Find your way into Scentian Bio

1,287 people in our graph share verified history with the Scentian Bio team — schools, employers, funds. One of them is your warm intro.

Laura Buhlerunlockedknows Jonathan Good · together at McKinsey & Company (overlapped)
×4knows the team · via McKinsey & Company
×5knows the team · via University of Oxford
×2knows the team · via Credit Suisse First Boston

Scentian Bio combines synthetic biology and AI to develop biosensors based on synthesized insect odorant receptors, creating a digital sense of smell and taste that can detect and measure the concentration of thousands of compounds. Spun out of Plant & Food Research, the company holds patents around its odorant-receptor biosensing technology.

Founders & leadership

Scentian Bio was founded in 2021 by Andrew Králíček.

AKAndrew Králíček
Andrew KrálíčekinFounder & Chief Technology OfficerAndrew Králíček is a molecular biologist and Founder & Chief Technology Officer of Scentian Bio, which develops biosensors using synthetic insect odorant receptors for chemical detection. He previously led government-funded research programs in insect olfaction that contributed to the company's founding in 2021.
JGJonathan Good
Jonathan GoodinChief Executive OfficerChief Executive Officer of Scentian Bio, a biosensor company spun out of Plant & Food Research. Good has held executive positions across technology, marketing, and operations.
CCColm Carraher
Colm CarraherinChief Scientific OfficerHe has conducted research on insect olfaction mechanisms, odorant receptors, and protein structure-function relationships, with expertise in cell-based assays for characterizing odorant receptor ligands and their binding specificity.
NLNikki Lorigan
Nikki LoriganChief Financial Officer

Investors · 12

Also in the syndicate · 5

BoosterCultivate VenturesNew Zealand Growth Capital PartnersNZGCPOur Crowd

Funding

SEC filings, press & company announcements

$9.1M disclosed across 2 rounds · 2023–2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Scentian Bio do?
Scentian Bio combines synthetic biology and AI to develop biosensors based on synthesized insect odorant receptors, creating a digital sense of smell and taste that can detect and measure the concentration of thousands of compounds. Spun out of Plant & Food Research, the company holds patents around its odorant-receptor biosensing technology.
Who founded Scentian Bio?
Scentian Bio was founded by Andrew Králíček in 2021.
Who are Scentian Bio's investors?
Scentian Bio's investors include Booster Innovation Fund, DYDX Capital, Sprout, Finistere Ventures, Icehouse Ventures, OurCrowd, Toyota Ventures.
How much funding has Scentian Bio raised?
Scentian Bio has disclosed $9.1M raised across 2 rounds.